Matches in Wikidata for { <http://www.wikidata.org/entity/Q97592291> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q97592291 description "article scientifique publié en 2020" @default.
- Q97592291 description "articolo scientifico (pubblicato il 2020)" @default.
- Q97592291 description "artikull shkencor i botuar më 01 janar 2020" @default.
- Q97592291 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q97592291 description "im Jahr 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q97592291 description "scientific article published on 01 January 2020" @default.
- Q97592291 description "wetenschappelijk artikel" @default.
- Q97592291 description "наукова стаття, опублікована 1 січня 2020" @default.
- Q97592291 description "научна статия" @default.
- Q97592291 name "[A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM® AEROSOL) IN LONG-TERM ADMINISTRATION (24 WEEKS) IN JAPANESE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA]" @default.
- Q97592291 name "[A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM® AEROSOL) IN LONG-TERM ADMINISTRATION (24 WEEKS) IN JAPANESE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA]" @default.
- Q97592291 name "[A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM® AEROSOL) IN LONG-TERM ADMINISTRATION (24 WEEKS) IN JAPANESE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA]" @default.
- Q97592291 type Item @default.
- Q97592291 label "[A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM® AEROSOL) IN LONG-TERM ADMINISTRATION (24 WEEKS) IN JAPANESE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA]" @default.
- Q97592291 label "[A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM® AEROSOL) IN LONG-TERM ADMINISTRATION (24 WEEKS) IN JAPANESE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA]" @default.
- Q97592291 label "[A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM® AEROSOL) IN LONG-TERM ADMINISTRATION (24 WEEKS) IN JAPANESE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA]" @default.
- Q97592291 prefLabel "[A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM® AEROSOL) IN LONG-TERM ADMINISTRATION (24 WEEKS) IN JAPANESE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA]" @default.
- Q97592291 prefLabel "[A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM® AEROSOL) IN LONG-TERM ADMINISTRATION (24 WEEKS) IN JAPANESE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA]" @default.
- Q97592291 prefLabel "[A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM® AEROSOL) IN LONG-TERM ADMINISTRATION (24 WEEKS) IN JAPANESE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA]" @default.
- Q97592291 P1433 Q97592291-931E412C-679D-4EB1-98A9-ADD9A37653FA @default.
- Q97592291 P1476 Q97592291-B1D211A6-FB08-4E02-9069-1785462D91FC @default.
- Q97592291 P2093 Q97592291-64CCA6AD-A0DF-4B4C-B593-F2DADACE5E47 @default.
- Q97592291 P2093 Q97592291-B18F51FE-7DB2-41A3-B870-E1D38A73F3E9 @default.
- Q97592291 P2093 Q97592291-E7AA062A-63F5-4670-A7E5-1398790BC652 @default.
- Q97592291 P304 Q97592291-9AC838BB-EB41-4977-9AFE-4CF861F73FF8 @default.
- Q97592291 P31 Q97592291-6A69965B-56EC-4651-8487-EC89884301DF @default.
- Q97592291 P356 Q97592291-C86B167C-49EF-483C-BCB1-92434A4E39A4 @default.
- Q97592291 P433 Q97592291-EC3D68D0-ECF0-4CB5-91AD-90137E4AE62A @default.
- Q97592291 P478 Q97592291-BF39CD4E-2314-4986-BFC1-C7DF7B1D0024 @default.
- Q97592291 P577 Q97592291-33D3087D-B2CC-46A7-90A9-E72E733032F2 @default.
- Q97592291 P698 Q97592291-687F69DC-0A60-436F-950B-C169F53E6D54 @default.
- Q97592291 P356 ARERUGI.69.341 @default.
- Q97592291 P698 32684549 @default.
- Q97592291 P1433 Q27709192 @default.
- Q97592291 P1476 "[A PHASE III STUDY TO EVALUATE SAFETY AND EFFICACY OF FLUTICASONE/FORMOTEROL COMBINATION (FLUTIFORM® AEROSOL) IN LONG-TERM ADMINISTRATION (24 WEEKS) IN JAPANESE PEDIATRIC PATIENTS WITH BRONCHIAL ASTHMA]" @default.
- Q97592291 P2093 "Miho Kamata" @default.
- Q97592291 P2093 "Toshio Katsunuma" @default.
- Q97592291 P2093 "Yasuyuki Ishikawa" @default.
- Q97592291 P304 "341-352" @default.
- Q97592291 P31 Q13442814 @default.
- Q97592291 P356 "10.15036/ARERUGI.69.341" @default.
- Q97592291 P433 "5" @default.
- Q97592291 P478 "69" @default.
- Q97592291 P577 "2020-01-01T00:00:00Z" @default.
- Q97592291 P698 "32684549" @default.